ISOTRETINOIN
| Brand name | ABSORICA LD |
|---|---|
| Active ingredient | ISOTRETINOIN |
| Strength | 28MG |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | November 2019 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 9700535 | August 2035 | product |
| 9750711 | May 2035 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.